Most Promising Applications of Artificial Intelligence (AI) in Healthcare Segment

Rare Diseases

Hemophilia B Market: How Pipeline Therapies are...

An X-linked recessive disorder, Hemophilia occurs predominantly in males with females being the carriers. Patients diagnosed with Hemophilia usually lack one of the two proteins essential for the b...

Mar 15, 2021

Hemophilia Market | A rare bleeding disorder | A royal disease
A Royal Disease: Hemophilia

A Royal Disease: Hemophilia  During the 19th-century British monarch's son Leopold, Duke of Albany slipped and died of blood loss. Not only once, but Queen Victoria’s grandsons died at a comparatively younger age. Thus, it was thought that male descendants of the royal family are cursed. Hence, the assumed ...

Find More
Rare Cancer Market | Soft Tissue Sarcoma Market | Multiple Myeloma Market | Glioblastoma Multiforme Market | Cholangiocarcinoma Market | Synovial Sarcoma Market
Rare Cancer Market: A Global Crusade on what is a ‘less common cancer’?

Cancer is often challenging, however, diagnosis of rare cancer poses extra difficulties. Of all the diagnosed cancers, approximately 22% of the cases are rare cancers. According to the US National Cancer Institute, a cancer rare cancers as those with an incidence of fewer than 15 cases per 100 000 per year. Rare...

Find More
Rare Disease Market Drivers | Orphan Drugs
What are the Market Drivers Fueling the Rare Disease Market?

Rare diseases–also go by the name Orphan diseases–are the conditions that do not affect many individuals out there in one particular geographic area. Going deeper into the definition, it also means a lesser patient pool for a therapy developed for one identified rare condition. Unfavorable drug uptake would automat...

Find More

More Views & Analysis

recent-pharma-biotech-news-updates-happenings-for-beam-grail-quest-diagnostics
Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer

Beam adds to drug delivery stable with USD 120 Million GuideTx buy Beam Therapeutics has taken over a startup whose technology could proffer the biotech’s genetic medicines to more tissues in the body, widening the potential to approach more diseases. Beam announced that it paid USD 120 million upfront to acq...

Find More

Erythropoietic Protoporphyria Market Outlook
Emerging Research Continues To Transform Erythropoietic Protoporphyria Market Outlook

Lack of knowledge about conditions, situations, or body ailments that are unexplainable often scares people and leads to people jumping to conclusions or say myths that are not at all backed by science and logic. Myths are a seemingly convenient way to explain what the mind perceives as unexplainable.  This...

Find More

Hypofibrinogenemia Market | Rare Bleeding Disorders
Hypofibrinogenemia Market: Limited Pipeline Therapies, Abundant Opportunities

Like troops at the forefront of any battle, our immune system continually marches to protect us from foreign elements and invaders, including bacteria, viruses, and others. Whenever with a swift wave of wind, something falls in our eyes, our immune system produces tears to get rid of the invader. Or at times when w...

Find More

Rare diseases challenges | Rare diseases clinical trials, incidence, and funding
The Paradox of Rare: Chalking out Challenges in the Rare Disease Market

How is a Rare disease defined? Well, it depends on the geography in question, since there is no universal definition, even so, the definition revolves around the point of prevalence or incidence of rare disease. If we talk about the United States, a rare disease affects fewer than 200,000 people (Orphan Drug Act). ...

Find More

Rare Diseases Incidence | Rare Disease Market | Synovial sarcoma | Argininosuccinic aciduria | Biliary atresia
Limited Therapies in the Rare Disease Pipeline: Watch out for Rare Indications that Calls Out for Novel Therapies

Rare diseases affect a small percent of the population. In the United States, a rare disease is a condition that affects fewer than 200,000 people in the US (Orphan Drug Act ). In the European Union, a rare disease affects fewer than 1 in 2,000 people. Similarly, different federations follow different definitions t...

Find More

Hemophagocytic Lymphohistiocytosis Treatment Market
A Bleak Pipeline and Lack of Approved Treatment Clouds the Hemophagocytic Lymphohistiocytosis Market Size Growth

Having a strong immune system, flourished with properly working immune cells is the ultimate key to surviving a healthy life. However, what if a person is in possession of overactive immune cells? It leads to improper functioning of the immune system, confusing internal organs as foreign invaders thus attacking the...

Find More

A chronic pain condition, Complex Regional Pain Syndrome (CRPS) often affects one limb and is believ.....

Find More

Celiac disease is an autoimmune disorder against the gluten consumed that creates toxins, thereby, d.....

Find More

Gastroesophageal Reflux Disease (GERD, also known as chronic acid reflux) is a digestive disorder in.....

Find More

Cocaine Use Disorder (CUD) is characterized as a substance use disorder in which biological, psychol.....

Find More

Managing patients virtually, the most important healthcare trend of 2020, is a process where healthc.....

Find More

Progressive Supranuclear Palsy (PSP) is a rare progressive disorder resulting from damage that occur.....

Find More